Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026)
Dyne Therapeutics' (DYN) quarterly Prepaid Assets came in at $48.9 million in Q1 2026, up 306.89% year-on-year from $12.0 million in Q1 2025, and up 204.97% on a QoQ basis from $16.0 million in Q4 2025.
Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has 8 years of Prepaid Assets data on file, last reported at $48.9 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 306.89% year-over-year to $48.9 million in Q1 2026; TTM through Mar 2026 was $48.9 million, a 306.89% increase from a year earlier, with the FY2025 full-year figure at $16.0 million, down 5.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $48.9 million, up from $16.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for DYN reached as high as $48.9 million in Q1 2026 and fell as low as $5.4 million in Q2 2023.
- Historically, Prepaid Assets has averaged $15.5 million across 5 years, with a median of $12.7 million in 2024.
- On a YoY basis, Prepaid Assets climbed as much as 434.77% in 2022 and fell as far as 76.29% in 2022.
- Year by year, Prepaid Assets stood at $9.6 million in 2022, then plunged by 34.51% to $6.3 million in 2023, then jumped by 171.09% to $17.0 million in 2024, then declined by 5.8% to $16.0 million in 2025, then soared by 204.97% to $48.9 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $48.9 million in Q1 2026, $16.0 million in Q4 2025, and $14.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Dyne Therapeutics | 3.94 Bn | 3.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.87 Mn |
| Dec 31, 2025 | 16.03 Mn |
| Sep 30, 2025 | 14.38 Mn |
| Jun 30, 2025 | 14.03 Mn |
| Mar 31, 2025 | 12.01 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 12.72 Mn |
| Jun 30, 2024 | 13.48 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 10.39 Mn |
| Jun 30, 2023 | 5.44 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 9.58 Mn |
| Sep 30, 2022 | 10.09 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 21.30 Mn |
| Dec 31, 2021 | 5.82 Mn |
| Sep 30, 2021 | 17.13 Mn |
| Jun 30, 2021 | 25.71 Mn |